Pain: Clinical Trials

121 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

121 recruiting. 121 Phase 2, 21 Phase 3, 16 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2121Recruiting 121
Phase 321Recruiting 21
Phase 116Recruiting 16

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 121 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period
Arumakimig, Placebo, Oral glucocorticoids - VEXAS Syndrome
Phase 2RecruitingNovartis Pharmaceuticals1202026-10-302026-10-13
A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
Cebranopadol, Placebo - Chronic Pain, Pain
Phase 2RecruitingAdneuris Therapeutics, Inc.452026-10-012026-10-23
Dexmedetomidine as an Adjuvant to Greater Auricular Nerve Block in Middle Ear Surgeries
Bupivacaine, Dexmedetomidine, Normal saline - Postoperative Pain, Middle Ear Surgery
Phase 2RecruitingMinia University402026-09-252026-10-16
A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction
CYT-1010, Placebo - Acute Postoperative Pain, Dental Pain
Phase 1 / Phase 2RecruitingCytogel Pharma, LLC322026-09-252026-10-29
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment
Lidocaine (drug), Saline - Refractory Migraine, Headache
Phase 2RecruitingDaniel A Tonetti, MD802026-09-092026-10-01
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
LY4065967, Placebo - Chronic Pain, Low Back Pain
Phase 2RecruitingEli Lilly and Company1502026-08-122026-09-04
Psilocybin to Treat Depression in Spinal Cord Injury
Psilocybin (Usona Institute) - Spinal Cord Injury, Depression - Major Depressive Disorder
Phase 1 / Phase 2RecruitingJames J. Peters Veterans Affairs Medical Center302026-08-062026-08-10
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia
HL-1186, HL-1186 placebo, Pregabalin capsule - Postherpetic Neuralgia ( PHN )
Phase 2RecruitingShanghai Yidian Pharmaceutical Technology Development Co., Ltd.2002026-08-012026-08-11
Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia
Standard Bupivacaine, Liposomal Bupivacaine - Pain, Postoperative
Phase 2RecruitingWashington University School of Medicine452026-08-012026-08-18
Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children
RADA16 hydrogel - Postoperative Pain
Phase 2RecruitingRutgers, The State University of New Jersey1342026-07-092026-07-22
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
Genicular Artery Embolization, Lipiodol, Simple angiogram - Knee Osteoarthritis, Knee Osteoarthritis (Knee OA)
Phase 2RecruitingUniversity of Utah402026-07-012026-10-30
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
LY4065967, Placebo - Osteoarthritis, Knee, Chronic Pain
Phase 2RecruitingEli Lilly and Company1502026-06-252026-09-04
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
Lidocaine hydrochloride, Methylprednisolone sodium succinate - Headaches Associated With Subarachnoid Hemorrhage (SAH)
Phase 2RecruitingDaniel Raper, MBBS252026-06-232026-07-08
Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperative Pain
ondansteron - Acue Postoperative Pain
Phase 1 / Phase 2RecruitingAssiut University202026-06-012026-07-15
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery
HL-1186, HL-1186 placebo, Oxycodone-Acetaminophen - Postoperative Pain
Phase 2 / Phase 3RecruitingShanghai Huilun Pharmaceutical Co., Ltd.3302026-05-112026-07-16
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery
HL-1186, HL-1186 placebo, Oxycodone-Acetaminophen - Postoperative Pain
Phase 2 / Phase 3RecruitingShanghai Huilun Pharmaceutical Co., Ltd.3302026-05-092026-07-13
Virtual Menstrual Pain Approaches in Females
Virtual Auricular Acupressure, Virtual Baduanjin Qigong Exercise, Self Education - Pain (Visceral, Somatic, or Neuropathic), Women of Reproductive Age
Phase 2 / Phase 3RecruitingNanyang Technological University1452026-04-152026-06-23
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed - Recurrent Acute Pancreatitis, Chronic Pancreatitis
Phase 1 / Phase 2RecruitingOhio State University352026-04-022026-10-20
A Study of LY4515100 in Participants With Pain Following Third Molar Removal
LY4515100, Placebo - Acute Pain, Molar
Phase 2RecruitingEli Lilly and Company2122026-04-012026-05-01
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Ketamine Infusion, Mindfulness-based cognitive therapy - Chronic Pain, Posttraumatic Stress Disorder (PTSD)
Phase 1 / Phase 2RecruitingDr. Yuliya Knyahnytska302026-03-312026-09-15

Showing 20 of 121. Sign in to see all of them.

Narrower conditions

Chronic Pain (27)  ·  Pain, Postoperative (27)  ·  Neuralgia (10)  ·  Headache (9)  ·  Depression (7)  ·  Acute Pain (6)  ·  Agnosia (6)  ·  Anxiety Disorders (6)  ·  Opioid-Related Disorders (6)  ·  Arthralgia (5)  ·  Cancer Pain (4)  ·  Low Back Pain (4)  ·  Osteoarthritis (4)  ·  Osteoarthritis, Knee (4)

Broader conditions

Neurologic Manifestations (121)  ·  Pathological Conditions, Signs and Symptoms (121)  ·  Signs and Symptoms (121)  ·  Pathologic Processes (39)  ·  Nervous System Diseases (36)  ·  Postoperative Complications (28)  ·  Mental Disorders (23)  ·  Behavior (14)  ·  Neuromuscular Diseases (14)  ·  Musculoskeletal Diseases (13)  ·  Joint Diseases (12)  ·  Peripheral Nervous System Diseases (12)  ·  Central Nervous System Diseases (11)  ·  Brain Diseases (10)

Interventions

Sodium Chloride (9)  ·  Cannabidiol (5)  ·  Lidocaine (5)  ·  Saline Solution (5)  ·  Dexamethasone (4)  ·  Bupivacaine (3)  ·  Dexmedetomidine (3)  ·  Dronabinol (3)  ·  Ketamine (3)  ·  Pregabalin (3)  ·  Psilocybin (3)  ·  Botulinum Toxins, Type A (2)  ·  Clonidine (2)  ·  Diclofenac (2)  ·  Exercise (2)

Sponsors

Eli Lilly and Company (3)  ·  Massachusetts General Hospital (3)  ·  Rutgers, The State University of New Jersey (3)  ·  Sahiwal medical college sahiwal (3)  ·  Stanford University (3)  ·  University of Maryland, Baltimore (3)  ·  VA Office of Research and Development (3)  ·  Brigham and Women's Hospital (2)  ·  Northwell Health (2)  ·  Shanghai Huilun Pharmaceutical Co., Ltd. (2)  ·  University Health Network, Toronto (2)  ·  University of British Columbia (2)  ·  University of California, Davis (2)  ·  University of California, San Francisco (2)  ·  University of Colorado, Boulder (2)

Countries

United States (68)  ·  Canada (14)  ·  China (8)  ·  Pakistan (7)  ·  France (3)  ·  Spain (3)  ·  Denmark (2)  ·  Egypt (2)  ·  Israel (2)  ·  Poland (2)  ·  Puerto Rico (2)  ·  Singapore (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)

Top investigators

Adeel Riaz, MD (3)  ·  Amber Brooks, MD (1)  ·  Amir Minerbi, MD-PhD (1)  ·  Anthony Mathur (1)  ·  Antoine Roger (1)  ·  Arash Afshari, PhD (1)  ·  Areeba Maryam, BDS (1)  ·  Ari Green, MD, MCR (1)  ·  Asokumar Buvanendran, MD (1)  ·  Bernardino Clavo, MD, PhD (1)  ·  Brett Johnson, MD (1)  ·  Brian Louie, M.D. (1)  ·  Brian Wainger, MD PhD (1)  ·  Bruno Chumpitazi, MD, MPH (1)

Results publications

PMID 11853818, PMID 12907905, PMID 16400513, PMID 16437520, PMID 17312203, PMID 18844269, PMID 19260079, PMID 21427067, PMID 21575276, PMID 21674151, PMID 23102757, PMID 23549581, PMID 24550805, PMID 24687190, PMID 24733808, PMID 25699252, PMID 27578767, PMID 28409480, PMID 28704354, PMID 28990015, PMID 29577509, PMID 29764303, PMID 31779159, PMID 32371500, PMID 32379556, PMID 32633773, PMID 33134600, PMID 33738491, PMID 34867525, PMID 35001856, PMID 36044208, PMID 36048469, PMID 36357803, PMID 36532184, PMID 36619264, PMID 36798353, PMID 38528704, PMID 38862073, PMID 38951902, PMID 39138719, PMID 39260823, PMID 39979051, PMID 40192825, PMID 41831719, PMID 42267534

NIH funding

2023 (2), 1RM1NS128741-01 (1), 2019 (1), I01RX004287 (1), IK2CX002646-01A2 (1), P01NS119159 (1), P30AG022845 (1), R01AG082777 (1), R01AT011341 (1), R01AT013240 (1), R01DA056045 (1), R01DA058620 (1), R01DA060066 (1), R01DK138871 (1), R21AR082123 (1)